Read + Share

Amedeo Smart

Independent Medical Education


Read + Share

Shupak A. Letter to the Editor: Comment on "Evaluating the Efficacy of Intratympanic Dexamethasone in Protecting Against Irreversible Hearing Loss in Patients on Cisplatin-Based Cancer Treatment: A Randomized Controlled Phase IIIB Clinical Trial" (Moreno and Be Ear Hear 2022 Mar 8. pii: 00003446-900000000-98350.
PMID: 35298115


Free Medical Abstracts
Privacy Policy
Sponsors
Share
About

© Amedeo 1997-2016